Skip to main content
RH

RheumaGen

Aurora, United States
Last funding
Undisclosed
Series ADec 2025

RheumaGen develops a class of cell and gene therapy treatments aimed at autoimmune diseases.

Backed bySPRIM Global InvestmentsBeyond Celiac InvestmentsWilliam Taylor Nominees

About RheumaGen

Who are RheumaGen's investors?

RheumaGen's investors include SPRIM Global Investments, Beyond Celiac Investments, William Taylor Nominees.

Where is RheumaGen headquartered?

RheumaGen is headquartered in Aurora, United States.

What does RheumaGen do?

RheumaGen develops a class of cell and gene therapy treatments aimed at autoimmune diseases.

What stage is RheumaGen at?

RheumaGen is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"RheumaGen — Funding & Investors." VCBacked, December 22, 2025, https://www.vcbacked.co/company/rheumagen. Accessed November 15, 2026.
APA
VCBacked. (2025). RheumaGen — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/rheumagen
Wikipedia (cite web)
{{cite web |title=RheumaGen — Funding & Investors |url=https://www.vcbacked.co/company/rheumagen |website=VCBacked |access-date=November 15, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at RheumaGen? Request a listing update

Founder contacts
m***@rheumagen.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →